In-Depth Analysis of Recent Deal Activity and Pharmaceutical Deal Trends (2010-2015) | Latest Research Report

Researchmoz added Most up-to-date research on "Pharmaceutical Deal Trends (2010-2015) and In-Depth Analysis of Recent Deal Activity" to its huge collection of research reports.

GBI Research’s latest report, ""Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity"" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances. It also examines preference by deal type, along with disclosed deal values from 2010 to July 2015, covering start-ups, mid-level players, and big players.

Pharmaceutical companies use deal activity to enhance their research activities, regulatory approach, geographic presence, commercialization, and sales. The increasing development of biologics, especially in oncology, has given a significant boost to activity in recent years. Analysis suggests that while the number of deals in 2015 (until July) was lower than the number of deals in 2014, deal value in 2015 has already exceeded that of 2014. Looking at the entire period, although strategic deals were more numerous, M&A deals had the highest deal value. Partnerships were the most preferred type of deal activity, but saw the lowest deal value. North America led in terms of region, followed by Europe and Asia-Pacific. Key deals covered in this report include the acquisition of Allergen by Actavis, asset transactions between Novartis and GlaxoSmithKline, and the partnership between Pfizer and Merck.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=399070

Scope

- Which challenges in the pharmaceutical industry are encouraging deal activity?
- How important is deal activity to the market?

Overview of deal activity from 2010 to 2015 -

- What are the trends for M&A and strategic deals, and what are the key differences between the sectors?
- What was the trend for regional involvement in each year?
- How do variations in terms of therapy area preference affect deal activity?

Detailed analysis of recent deal activity -

- How do announced and completed deals vary?
- How do deals in 2014 and 2015 compare in terms of quarterly volume and value?
- Which regions or therapy areas have encouraged recent deal activity?
- Who are the key players?

Complete analysis of recent M&A deals -

- How do M&A deal types differ in terms of number and value?
- Which regions and therapy areas have been involved in M&A deals since 2013?
- Who are the most important players in M&A deals?
- What was the rationale behind key M&A deals?

Complete analysis of recent strategic alliances -

- What are the different strategic alliance deal types?
- Which key regions and therapy areas have been involved in strategic alliances since 2013?
- Which important molecule types and routes of administration have recently been involved in strategic alliances?
- Who are the key players in strategic alliance deals?
- What was the rationale behind key strategic alliance deals?

Reasons to buy

This report will allow you to -
- Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals
- Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals.
- Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development.
- Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=399070

New Survey on Parkinsons Disease Therapeutics in Major Developed Markets to 2021 | Researchmoz.us

Researchmoz added Most up-to-date research on "Parkinsons Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments" to its huge collection of research reports.

Parkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinson's Disease (PD) prevalence was estimated at 16.1 million in 2011, and after Alzheimer's disease it is the second most common neurodegenerative disease worldwide.

Parkinson's Disease (PD) is a progressive disease and, although not fatal, it can develop severe symptoms and complications that significantly impact upon the patient's quality of life. Symptoms for each stage can be categorized into early, moderate and advanced stages. Major motor symptoms of Parkinson's Disease (PD) include tremors and difficulty walking. Parkinson's Disease (PD) also gives rise to non-motor symptoms, such as dementia, depression, hallucinations and loss of taste and smell.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=668356

There are several different drug classes available to relieve Parkinson's Disease (PD) symptoms. The aim is for treatments to increase dopamine levels, which is substantially diminished in brains affected by Parkinson's Disease (PD). The most common therapies include levodopa, dopamine agonists and Monoamine Oxidase-B (MAO-B) inhibitors, with the choice of therapies dependent on patient symptoms and lifestyle. As the disease develops, the medication will need to be taken more strictly, due to the effect of drugs wearing off (known as offtime), which causes symptoms to return before the next dose.

With the current marketed drugs focusing primarily on symptomatic relief, Parkinson's Disease (PD) remains incurable, with a huge unmet need for disease-modifying therapies. However, due to the lack of clearly established clinical trial methodologies, replication of the benefits demonstrated by neuroprotective agents in the laboratory to human trials has proved challenging. More importantly, due to an incomplete understanding of the underlying mechanisms that cause the disease, a viable therapeutic target to halt or slow disease progression is currently not in scope, which limits the effectiveness of current product development programs.

Scope

- A brief introduction to Parkinson’s Disease (PD), including pathogenesis, disease staging, diagnosis and treatment algorithms
- Comprehensive analysis of the drugs available for the treatment of PD, covering their safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat map comparing drugs in terms of safety and efficacy
- Comprehensive analysis of the pipeline for Parkinson’s Disease (PD) therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period, on the basis of Phase distribution, molecule type and molecular target
- Additional thorough analysis of pipeline drug clinical trials by Phase, molecule type, trial size, trial duration, and program failure rate for each molecule type and mechanism of action
- Multi-scenario market forecast data to 2021, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across the key developed markets of the US, Canada, Japan, Germany, the UK, France, Italy and Spain
- Discussion of the drivers of and barriers to market growth
- Discussion of the licensing and co-development deals landscape in Parkinson’s Disease (PD), by stage of development, molecule type and mechanism of action, as well as analysis of both licensing and co-development deals by year, and network maps of licensing and co-development deals

Reasons to buy

- Understand the different levels of Parkinson’s Disease (PD) therapy from early-stage to advanced
- Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent
- Observe the trends in clinical trial duration and size among clinical Phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or forthcoming developmental programs for Parkinson’s Disease (PD) therapeutics
- Observe the trends in clinical trial duration and size among clinical Phases, between molecule types and mechanisms of action, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for Parkinson’s Disease (PD) therapeutics
- Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the Parkinson’s Disease (PD) therapeutics market

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=668356

Non-Hodgkin Lymphoma Innovative Licensing Industry Opportunities Key Trends, Size, Growth, Shares And Forecast Research Report

Researchmoz added Most up-to-date research on "Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma" to its huge collection of research reports.

Non-Hodgkin Lymphoma (NHL) can be seen as a collection of up to 60 smaller subtypes of malignant lymphoid disease, defined by distinct morphological, cytogenetic and immunophenotypic characteristics that can be broadly classified as either indolent or aggressive disease. The slow growing nature of the former means that first-line treatment for diagnosed patients can be delayed, an option not commonly recommended for aggressive disease. Across both indolent and aggressive disease, first-line chemotherapy in combination with the blockbuster drug rituxumab can induce high rates of response, and prolonged durations of remission. Despite this, indolent disease is typically incurable, with the most aggressive lymphoma subtype - diffuse large B-cell lymphoma having 5-year survival rates of ~50%. Re-treatment with chemotherapy can induce second and subsequent remissions, but most NHL patients develop chemotherapy resistant disease, for whom there are limited treatment options. Overall, in terms of numbers small molecule chemotherapeutic agents dominate the current market, with a clear need for novel targeted therapies to prolong durations of remission, and provide options for patients with chemo resistant, heavily pretreated disease.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=373016

The current developmental pipeline addresses these gaps in the market, dominated by cancer immunotherapies and inhibitors of cancer-associated signal transduction. Pathways of significant interest include B-cell receptor signaling, the PI3K/Akt/mTOR pathway, and Wnt/ß-catenin signaling, as well as oncogenes such as BCL-6 and BCL-2. Characteristic cell surface molecules that represent targets for cancer immunotherapies include CD19, LMP-1/2 and CD20, with several pipeline drugs already approved for CD20. First-in-class drug development in NHL corresponds strongly to these known somatic mutations and affected pathways. Clinical results of drugs against profiled targets in this report show many are being investigated in relapsed disease.

Scope

There are 666 marketed products for NHL, 95% of which are small molecules -

- What are the dominant mechanisms of action across marketed products?

The treatment of lymphoma is dominated by the use of combination cyclophosphamide based chemotherapy in combination with rituximab -

- What are these chemotherapy regimens?
- How did they perform in key clinical trials?

The variation in molecule type has shifted away from small molecules, whose dominance has decreased to 46% across the pipeline -

- What are the dynamics of the remaining 54% of the pipeline?
- How does this reflect the need for novel targeted therapies?

There is a significant shift away from cytotoxic agents, with the current pipeline dominated by cancer immunotherapies and signal transduction inhibitors -

- What is the scientific rationale behind these mechanisms of action?
- How successful have approved targeted therapies been?

Profiled first-in-class therapies include: PIK3CA, EZH2, CD40 and MDM2 -

- What is the scientific rationale behind these targets?
- What preclinical and clinical results are available for drugs against these targets?
- What is the overall opinion on these targets for drug development across NHL?

Reasons to buy

This report will allow you to -

- Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis, prognosis and the available treatment options available at each stage of diagnosis.
- Visualize the composition of the NHL market in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
- Analyze the NHL pipeline, and stratify by stage of development, molecule type and molecular target. There are promising signs in focussed on the development of targeted therapies for this disease.
- Visualize the clinical safety and efficacy of drugs against first-in-class targets via a detailed heat map, outlining the results across major clinical trial endpoints.
- Identify commercial opportunities in the NHL deals landscape by analyzing trends in licensing and co-development deals, and those first-in-class drugs which are yet to be involved in a strategic alliance.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=373016

Latest Research Report on Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future

Researchmoz added Most up-to-date research on "Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future" to its huge collection of research reports.
 

"Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future" discusses fundamental concepts in biobanking and recent technology advancements in the field. The report also describes ethical and regulatory concerns in biobanking as well as the economic challenges and opportunities surrounding this industry. Furthermore, this report provides strategic recommendations on how to overcome some of the most critical economic, technological and ethical challenges facing this fast-growing sector.

Biobanks collect human biospecimens and associated data for medical-scientific research, and organize samples and data in a systematic way for use by others. The importance of biobanks lies in determining the most effective way to store that information and make it available when required. Biobanks may collect different samples from diseased or healthy individuals in various settings. The integration of novel tools such as big data techniques, coupled with the increasing industry need for high-quality biospecimens for research, will lead to expanding biospecimen collections, ultimately resulting in the growth of this sector. Biobanks currently exist on every continent with most located in North America, followed by Europe. Australia has the highest number of biobanks in the Asia-Pacific region whilst India has the highest number of biobanks, when considering the developing economies only.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=502551

The development of a biobank depends upon people's willingness to donate their samples for research and to agree to sample storage. The participation and support of the public is therefore of crucial importance as their attitude towards biobanking activities will determine the success of many of these organizations.

Scope

- What are the fundamentals of biobanking?
- How can biobanks be classified and what are their different applications in healthcare?
- What are the economic challenges faced by biobanks and how can these be overcome?
- What are the most recent technology advancements in biobanking?
- What role does biobanking play in drug discovery and clinical trials?
- How are biobanks distributed geographically?
- What are the prospects of Big Data and associated technologies within biobanking?
- What are the technological and legal challenges?
- What are the main healthcare opportunities that can be leveraged?
- What is the public attitude towards various biobanking activities?
- What are the challenges in obtaining informed consent from donors and what strategies can biobanks adopt to overcome these challenges?
- What are the current ethical and regulatory challenges in biobanking?
- What is the role and importance of the international charter of principles for data sharing between biobanks?
- What are the main intellectual property right opportunities and challenges within biobanking? How can biobanks overcome these challenges and mitigate potential risks?
- What is the need for process harmonization between biobanks?

Reasons to buy

This report will allow you to
- Gain insights in the biobanking industry: This report describes fundamental concepts in biobanking, biobank classification as well as economic, technological and ethical challenges surrounding these organizations. Learn how biobanks can overcome these challenges through best practice guidelines and strategic recommendations.
- Understand the role of biobanks in research and development: This report demonstrates the relationship between biobanks and R&D groups.
- Gain analysis on the distribution of biobanks in key regions and countries: This includes detailed analysis on the number of biobanks within each of the key regions and countries.
- Review and assess recent advances in biobanking technologies: This includes technology innovations in specimen collection, storage, temperature maintenance, consumables, data handling, transportation of biospecimens, and the integration of big data technologies in biobanking activities.
- Understand public views on biobanking activities: Learn about the various public concerns on biobanking, their attitude towards research, and how consent issues can be addressed through novel frameworks and technology adoption.
- Assess ethics, regulations, and harmonization needs in biobanking: This in-depth report provides analysis on ethical, regulatory and harmonization requirements in the biobanking sector.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=502551

New Study Reveals Hepatitis B Therapeutics in Major Developed Markets to 2021 | Researchmoz.us

Researchmoz added Most up-to-date research on "Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth" to its huge collection of research reports.

Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern. Incidence tends to be higher in countries with a significant number of migrants from medium and high-prevalence countries. Approximately 350 million people worldwide are infected with chronic hepatitis B, which causes significant morbidity and mortality. Around 780,000 patients die from hepatitis B each year, of which 650,000 deaths are due to complications such as cirrhosis and liver cancer. Despite this, diagnosis and treatment rates are poor, stemming from its asymptomatic nature.

Globally, the hepatitis B therapeutics market is served moderately well by the available products, of which Baraclude and Viread are the most frequently prescribed. However, both have received black-box warnings from the US Food and Drug Administration (FDA), meaning that the market has a high level of unmet need.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=373001

Scope

- The current hepatitis B market contains mainly nucleoside analog reverse transcriptase inhibitors, nucleotide analogs, and interferons.
- Will these drugs continue to dominate hepatitis B treatment?
- With 81 active pipeline molecules, most of the investigational drug candidates are small molecules and vaccines, comprising 64% of the pipeline.
- What are the most prominent small molecules and vaccines in the pipeline?
- Do the pipeline molecules offer advantages over commercially proven mechanisms?
- Analysis of clinical trials since 2006 has identified a high rate of attrition in hepatitis B products.
- How do failure rates vary by product stage of development, molecule type, and mechanism of action?
- How do other factors such as average trial duration and trial size influence the costs and risks associated with product development?
- Over the 2014

Table of Contents

1 Table of Contents 51.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 Classification 9
2.2 Pathophysiology 9
2.3 Etiology 11
2.4 Symptoms 12
2.5 Diagnosis 12
2.6 Epidemiology 13
2.7 Treatment and Management 15
2.8 Prognosis 16
2.9 Co-infection 17
2.9.1 HBV-HIV Co-infection 17
2.9.2 HBV-HDV Co-infection 17
2.9.3 HBV–HCV Co-infection 17

3 Marketed Products 18
3.1 Viread 18
3.1.1 Study 0102 18
3.1.2 Study 0103 18
3.2 Entecavir 19
3.2.1 Nucleoside-Inhibitor-Naive Subjects with Compensated Liver Disease (Studies AI463022 and AI463027) 20
3.2.2 Lamivudine-Refractory Subjects with Compensated Liver Disease (Study AI463026) 21
3.3 Pegasys (peg interferon a-2a) 23
3.4 Adefovir dipivoxil 25
3.4.1 Study 437 (HBeAg-Positive Chronic Hepatitis B Patients) 25
3.4.2 Study 438 (HBeAg-Negative Chronic Hepatitis B Patients) 25
3.4.3 Adefovir Treatment beyond 48 Weeks 27
3.4.4 Study 435 (Pre- and Post-liver Transplantation Subjects) 27
3.4.5 Study 461 (Clinical Evidence of Lamivudine Resistance Patients) 27
3.5 Tyzeka per Sebivo 28
3.5.1 NV-02B-007 GLOBE Trial 28
3.5.2 HBeAg-Positive Subjects 28
3.5.3 HBeAg-Negative Subjects 28
3.6 Comparative Efficacy and Safety 30

4 Pipeline Analysis 32
4.1 Overall Pipeline 32
4.2 Pipeline Analysis of Therapeutic Vaccines 33
4.3 Clinical Trials 35
4.3.1 Failure Rate 35
4.3.2 Failure Rate by Molecule Type 36
4.3.3 Failure Rate by Mechanism of Action 37
4.3.4 Patient Enrollment and Clinical Trial Size by Molecule Type 38
4.3.5 Duration 39
4.4 Competitive Clinical Trials Metrics Analysis 41
4.5 Promising Drug Candidates in Pipeline 41
4.5.1 GS-7340 (tenofovir alafenamide fumarate) 41
4.6 Therapeutic Vaccines in Pipeline 42
4.6.1 GS-4774 Therapeutic Vaccine with Oral Antiviral Treatment 42
4.6.2 ABX203 Therapeutic Vaccine with Nucleos(t)ide Analogs against HBeAg-Negative Chronic Hepatitis B 42
4.6.3 HB-110E Therapeutic DNA Vaccine 42
4.6.4 Therapeutic (Synthesized Peptide) HBV Vaccine (ePA-44) 43
4.6.5 INO-1800 with or without INO-9112 in Entecavir/Tenofovir-Treated HBeAg-Positive Chronic Hepatitis B Patients 44
4.6.6 TG1050 Therapeutic Vaccine 45

5 Market Forecast to 2021 46
5.1 Geographical Markets 46
5.2 Global Market 46
5.3 North America 47
5.3.1 Treatment Usage Patterns 47
5.3.2 Annual Cost of Therapy 48
5.3.3 Market Size 49
5.4 Top Five EU Markets 50
5.4.1 Treatment Usage Patterns 50
5.4.2 Annual Cost of Therapy 51
5.4.3 Market Size 52
5.5 Japan 53
5.5.1 Treatment Usage Patterns 53
5.5.2 Annual Cost of Therapy 54
5.5.3 Market Size 55
5.6 Drivers and Barriers in the Disease Market 55
5.6.1 Drivers 55
5.6.2 Barriers 56

6 Deals and Strategic Consolidations 58
6.1 Licensing Deals 58
6.1.1 OnCore Enters into Licensing Agreement with NeuroVive 61
6.1.2 Dynavax Enters into Licensing Agreement with Merck for Heplisav 61
6.1.3 Ligand Enters into Licensing Agreement with Chiva for Pradefovir and MB01733 61
6.2 Co-development Deals 61

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=373001

USA - Telecoms, Mobile, Broadband and Digital Media - Statistics and Analyses | Now Available at Researchmoz.us

Researchmoz added Most up-to-date research on "USA - Telecoms, Mobile, Broadband and Digital Media - Statistics and Analyses" to its huge collection of research reports.

USA’s mobile operators fast-tracking 5G developments

The US has one of the largest telecoms markets, which has given it a unique character based only regional licensing. Growth in the mobile subscriber base remains strong despite penetration levels of above 120%. Declining revenue from voice services is compensated for by high growth in mobile data use, itself supported by upgraded networks supporting LTE-based services. Smartphone penetration is also high, which also encourages mobile data use among subscribers. A number of operators, led by AT&T, have partnered with vendors to trial 5G technologies and services. AT&T aimed to develop commercial 5G services by late 2018, which would make it one of the firs carriers globally to do so. In addition, operators are working on the potential of NB-IoT, LTE-U and LTE-A technologies, in some respects as a precursor to 5G.

A major development in early 2017 was the complex reserve auction for spectrum in the 600MHz band, which raised more than $19 billion. Although network operators must wait for spectrum allocations to be concluded, the additional 70MHz made available will go far to supporting mobile broadband in rural areas, and improving network capacity.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1037726

Given the size of the US market, and the growing demand for data on both fixed and mobile networks, there is continuous pressure for operators to invest in fibre networks, and to push connectivity closer to consumers. In recent years the US has seen increased activity from regional players as well as the major telcos and cablecos. Much of this activity was stimulated by Google Fiber following its investments in a number of markets. Although Google Fiber began scaling back its efforts in late 2016, the company’s legacy has been profound. It encouraged the major providers to reduce pricing for their similar offers, stimulated interest among municipal leaders, and highlighted the fact that haphazard and potentially duplicated fibre deployments are no effective substitute for municipally-led wholesale fibre infrastructure accessable to any provider.

AT&T and Verizon have shifted their investment efforts from a hybrid fibre-copper architecture to pure fibre. AT&T expected to provide a 1Gb/s FttP service to 12.5 million premises by 2019, with a view to upgrading to XG(S)-PON within a few years. For its part, Verizon had a patchy experience with its FttN rollouts and so has chosen to switch deployment to FttP. At the same time a growing number of cablecos have launched DOCSIS3.1 services, able to provide data at 1Gb/s and above. Future HFC technologies promise considerably faster speeds in the years ahead.

This report provides analyses as well as key statistics and forecasts on the US mobile market, including CTIA data for 2015, telcos’ financial and operating data to Q4 2016 and recent market releases from the regulator. It also provides an assessment of telcos’ strategies, regulatory policies, and developments in the deployment of emerging technologies. The report also reviews the cable, DSL, Wi-Fi, WiMAX and fibre broadband markets, providing analyses on regulatory measures and an assessment of the major fibre deployments in progress.

Key developments:

- AT&T expecting to provide 5G services by late 2018;
- FCC authorises the use of LTE-U devices in the under-utilised 5GHz band;
- AT&T planning national LTE-M services by mid-2017;
- FCC considers both low-end and high-end spectrum bands for possible 5G use;
- FCC concludes 600MHz spectrum auction;
- Comcast expands DOCSIS3.1 markets;
- Altice Group acquires Suddenlink Communications and Cablevisión, rebrands as Altice USA;
- New York state proposal for $1 billion investment in broadband infrastructure, using state and private funds;
- Altice USA to deliver a 10Gb/s service across its footprint by 2022;
- Google Fiber puts on breaks;
- Report update includes company financial and operating data to Q4 2016, recent market developments.

Companies mentioned in this report:

AT&T, Verizon, Sprint Corporation, T-Mobile US, TracFone, MetroPCS Communications, Leap Wireless, Frontline, Alltel, US Cellular, Clearwire, Google, CenturyLink, Qwest, Frontier Communications, Windstream, Fairpoint, Cincinnati Bell, Comcast, HughesNet, ViaSat

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1037726

Global Mobile Operators Industry Regional Leaders Overview and Statistics | Researchmoz.us

Researchmoz added Most up-to-date research on "Global Mobile Operators - Regional Leaders - Overview and Statistics" to its huge collection of research reports.

International expansion has strengthened the operations of many mobile operators

In 2017 the global mobile market has its sights firmly set on the opportunities offered through mobile data as well as looking for potential new revenues streams presented by the enterprise sector, data mining, 5G and international expansion.

Mobile saturation has occurred in many of the developed markets and this has forced some of the operators to look for new opportunities – particularly those offered by expanding regionally or internationally. This has occurred in most regions of the world – and as a result some operators have become powerful and dominant regional leaders.

In Latin America, for example, the mobile market continues to be dominated by a small number of operators which each have businesses in multiple countries.  These include Telefónica Group; Mexico’s América Móvil, trading as Telcel in its domestic market and as Claro in the remaining 16 markets in the region; Telecom Italia, AT&T Mexico and Millicom International. The dominance of these operators is being gradually eroded however as a result of efforts by a number of national regulators to facilitate the entry of MVNOs and to encourage the participation of smaller players in spectrum auctions.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=685045

In the more developed markets of Asia, growth is shifting away from a focus on subscriber numbers  and towards the expansion of new generation platforms and increased data usage driven by value-added services and increased ARPUs. There are those companies such as SingTel, Vodafone, and Axiata (formerly Telekom Malaysia International) that have built a substantial presence around the Asian region beyond their own domestic market through their shareholdings in operators in multiple other markets.

In the Pacific region; the Australian mobile market is dominated by the three major mobile network operators Telstra, Optus, and Vodafone (VHA), though there are numerous MVNOs which have a significant market share. These have been able to offer LTE services on a wholesale basis since early 2016, thus encouraging growth in the LTE sector and cementing the role which MVNOs play in the overall market.

Fiji is one of the telecoms leaders in the South Pacific region, along with Papua New Guinea. Similar to many developing nations, it is heavily reliant on mobile technologies rather than fixed lines. The percentage of unique mobile subscribers in Fiji sits at around 69%. Vodafone Fiji Limited (VFL) and Digicel Fiji are the major mobile operators and the only MVNO is Australian company, Inkk Mobile which operates on VFL’s network.

Three mobile service operators provide services in Papua New Guinea including Digicel, Bmobile (Vodafone), and Citifon (Telikom PNG). However, in February 2017 it was announced that Dataco, Bmobile and Telikom PNG would be merged together to form Kumul Telikom. The three entities would be able to share resources and infrastructure, making it potentially more cost effective and competitive.

Although there are a large number of network operators across the African continent, and also smaller niche MVNO players, there are also a small number of pan-regional network operators. These include Millicom, Orange Group, Vodacom and Bharti Airtel. Some rationalisation of their operations continues as these players adjust their strategies to fit in with market positions and expectations.

There are a number of companies which have a large presence in the Middle East. Zain, Ooredoo and MTN are three examples of companies operating in multiple markets and the international players of Orange and Vodafone also operate in region.

As with Latin America and Africa, the European region is notable for having half a dozen pan-European operators with interests in several key markets. These main players include Deutsche Telekom, Telefónica, Vodafone Group, Hutchison and TeliaSonera. There has been much jostling among these operators as they seek to strengthen their presence in particular markets. This has in turn caused some disquiet among national regulators and European competition authorities, which are keen to preserve a quorum of key players (generally four) within a given market.

This BuddeComm publication provides a global overview of the mobile market, supported by statistics as well as an overview of the mobile markets for each major region of the world. Country case studies for each region are also included, along with identification of the major MNOs and MVNOs operating in each region/country.

Key developments:

- Data mining will be the next driver of mobile revenue;
- Mobile operators need to rethink their business models;
- For new ideas, the industry should look towards the OTT players;
- Operators in Latin America will need to invest in LTE infrastructure and enhance their mobile data and broadband offerings in a bid to secure revenue growth;
- Whilst there are still developing markets in Asia which are continuing to grow their mobile subscriber base at high annual rates, total market growth in the region has eased considerably in the last few years. This is not surprising given that a significant number of markets have well and truly saturated over the last year or so.
- Digicel, which has an expanding business across Samoa and Fiji in the Pacific, built a $500 million mobile network in PNG, becoming the country’s largest non-mining investor;
- Although ARPU remains relatively low for operators, considering the level of disposable income in the region, Africa remains a key area for investment among players;
- There are several dozen MVNOs in the US market, most of them small and with a regional focus;
- While population increases across Europe mean that there is a steady influx of new mobile subscribers, the market has a sufficiently high penetration rate that growth is largely lateral, in that subscribers are migrating from 2G to 3G and LTE networks. As a result, the proportion of 2G subscribers is falling sharply, and while there remains steady, if slow, growth in the 3G sector this will also begin to fall from late 2017 or 2018 as subscribers shift to LTE networks. This movement is being encouraged by network operators which hope to capitalise on revenue derived from greater take-up of mobile broadband and data services;
- Although MVNOs were late to arrive in the Middle East, several have launched services and captured market share. FRiENDi and Virgin Mobile MEA are two notable MVNOs which operate in several markets and there are a number of domestic players as well.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=685045

Alzheimers Disease - Pipeline Review, H1 2017 | Now Available at Researchmoz.us

Researchmoz added Most up-to-date research on "Alzheimers Disease - Pipeline Review, H1 2017" to its huge collection of research reports.

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H1 2017, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.

Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which is further responsible for the transmission of signals. Predisposing factors include age, heredity, cardiovascular diseases or diabetes and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability and aggressiveness.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alzheimer's Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alzheimer's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1038193

The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 23, 40, 62, 1, 251, 90 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 109 and 46 molecules, respectively.

Alzheimer's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alzheimer's Disease (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Alzheimer's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alzheimer's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alzheimer's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alzheimer's Disease (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alzheimer's Disease (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alzheimer's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1038193

Mobility Scooter Global Market Analysis Key Trends, Size, Growth, Shares And Forecast Research Report 2017

Researchmoz added Most up-to-date research on "Global Mobility Scooter Industry 2017, Trends and Forecast Report" to its huge collection of research reports.

Mobility Scooter Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Mobility Scooter basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Mobility Scooter Market;
3.) the North American Mobility Scooter Market;
4.) the European Mobility Scooter Market;
5.) market entry and investment feasibility;
6.) the report conclusion.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1039028

Table of Contents

Part I Mobility Scooter Industry Overview

Chapter One Mobility Scooter Industry Overview1.1 Mobility Scooter Definition
1.2 Mobility Scooter Classification Analysis
1.2.1 Mobility Scooter Main Classification Analysis
1.2.2 Mobility Scooter Main Classification Share Analysis
1.3 Mobility Scooter Application Analysis
1.3.1 Mobility Scooter Main Application Analysis
1.3.2 Mobility Scooter Main Application Share Analysis
1.4 Mobility Scooter Industry Chain Structure Analysis
1.5 Mobility Scooter Industry Development Overview
1.5.1 Mobility Scooter Product History Development Overview
1.5.1 Mobility Scooter Product Market Development Overview
1.6 Mobility Scooter Global Market Comparison Analysis
1.6.1 Mobility Scooter Global Import Market Analysis
1.6.2 Mobility Scooter Global Export Market Analysis
1.6.3 Mobility Scooter Global Main Region Market Analysis
1.6.4 Mobility Scooter Global Market Comparison Analysis
1.6.5 Mobility Scooter Global Market Development Trend Analysis

Chapter Two Mobility Scooter Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Mobility Scooter Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Mobility Scooter Market Analysis3.1 Asia Mobility Scooter Product Development History
3.2 Asia Mobility Scooter Competitive Landscape Analysis
3.3 Asia Mobility Scooter Market Development Trend

Chapter Four 2012-2017 Asia Mobility Scooter Productions Supply Sales Demand Market Status and Forecast4.1 2012-2017 Mobility Scooter Capacity Production Overview
4.2 2012-2017 Mobility Scooter Production Market Share Analysis
4.3 2012-2017 Mobility Scooter Demand Overview
4.4 2012-2017 Mobility Scooter Supply Demand and Shortage
4.5 2012-2017 Mobility Scooter Import Export Consumption
4.6 2012-2017 Mobility Scooter Cost Price Production Value Gross Margin

Chapter Five Asia Mobility Scooter Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
...
...
Chapter Six Asia Mobility Scooter Industry Development Trend
6.1 2017-2021 Mobility Scooter Capacity Production Overview
6.2 2017-2021 Mobility Scooter Production Market Share Analysis
6.3 2017-2021 Mobility Scooter Demand Overview
6.4 2017-2021 Mobility Scooter Supply Demand and Shortage
6.5 2017-2021 Mobility Scooter Import Export Consumption
6.6 2017-2021 Mobility Scooter Cost Price Production Value Gross Margin

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1039028

Global Smart Charger Market Analysis, Key Trends, Size, Growth, Shares And Forecast Research Report 2017

Researchmoz added Most up-to-date research on "Global Smart Charger Industry 2017, Trends and Forecast Report" to its huge collection of research reports.

Smart Charger Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Smart Charger basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Smart Charger Market;
3.) the North American Smart Charger Market;
4.) the European Smart Charger Market;
5.) market entry and investment feasibility;
6.) the report conclusion.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1038975

Table of Contents

Part I Smart Charger Industry Overview

Chapter One Smart Charger Industry Overview1.1 Smart Charger Definition
1.2 Smart Charger Classification Analysis
1.2.1 Smart Charger Main Classification Analysis
1.2.2 Smart Charger Main Classification Share Analysis
1.3 Smart Charger Application Analysis
1.3.1 Smart Charger Main Application Analysis
1.3.2 Smart Charger Main Application Share Analysis
1.4 Smart Charger Industry Chain Structure Analysis
1.5 Smart Charger Industry Development Overview
1.5.1 Smart Charger Product History Development Overview
1.5.1 Smart Charger Product Market Development Overview
1.6 Smart Charger Global Market Comparison Analysis
1.6.1 Smart Charger Global Import Market Analysis
1.6.2 Smart Charger Global Export Market Analysis
1.6.3 Smart Charger Global Main Region Market Analysis
1.6.4 Smart Charger Global Market Comparison Analysis
1.6.5 Smart Charger Global Market Development Trend Analysis

Chapter Two Smart Charger Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Smart Charger Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Smart Charger Market Analysis3.1 Asia Smart Charger Product Development History
3.2 Asia Smart Charger Competitive Landscape Analysis
3.3 Asia Smart Charger Market Development Trend

Chapter Four 2012-2017 Asia Smart Charger Productions Supply Sales Demand Market Status and Forecast4.1 2012-2017 Smart Charger Capacity Production Overview
4.2 2012-2017 Smart Charger Production Market Share Analysis
4.3 2012-2017 Smart Charger Demand Overview
4.4 2012-2017 Smart Charger Supply Demand and Shortage
4.5 2012-2017 Smart Charger Import Export Consumption
4.6 2012-2017 Smart Charger Cost Price Production Value Gross Margin

Chapter Five Asia Smart Charger Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
...
...
Chapter Six Asia Smart Charger Industry Development Trend
6.1 2017-2021 Smart Charger Capacity Production Overview
6.2 2017-2021 Smart Charger Production Market Share Analysis
6.3 2017-2021 Smart Charger Demand Overview
6.4 2017-2021 Smart Charger Supply Demand and Shortage
6.5 2017-2021 Smart Charger Import Export Consumption
6.6 2017-2021 Smart Charger Cost Price Production Value Gross Margin

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1038975

Global Dual Lens Camera Smartphone Industry Key Trends, Size, Growth, Shares And Forecast Research Report (2017-2021)

Researchmoz added Most up-to-date research on "Global Dual Lens Camera Smartphone Market: Size, Trends & Forecasts (2017-2021)" to its huge collection of research reports.

The report entitled “Global Dual Lens Camera Smartphone Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global dual lens camera market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value and by segmentation. The report also provides the analysis of the global dual lens camera smartphone market of the China region.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global dual lens camera smartphone market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1042011

Apple Inc., Huawei Technologies Co. Ltd, LG Electronics Inc., and HTC Corporation are some of the key players operating in the global dual lens camera smartphone market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided

Country Coverage

- China

Company Coverage

- Apple Inc.
- Huawei Technologies Co. Ltd
- LG Electronics Inc.
- HTC Corporation

Executive Summary

Dual lens camera refers to a camera with two separate lenses to makes the picture more vivid and detailed. A dual lens camera consist of two or more lenses with a separate image sensor or film frame for each lens, placed side by side horizontally or vertically. The device enclose two completely independent camera modules, one is primary and other is secondary.

The dual camera can be categorized in four categories: Twin Type Dual Lens Camera(Color + Color, Color + Black/White), Depth Type Dual Lens Camera, Ad Hoc Type Dual Lens Camera, Optical Zoom Type Dual Lens Camera. The component of dual lens camera are: lenses (Wide-Angle Lenses, Normal Lenses, Telephoto Lenses, Prime Lenses), Image Sensor, Actuator, VCM (Voice Coil Motor), Pixel Types.

The global dual lens camera smartphone market is expected to increase at high growth rates during the forecasted period (2017-2021). The global dual lens camera smartphone market is supported by various growth drivers, such as increasing disposable income, increasing smartphone users worldwide, production capacity expansion, benefit to supply chain, DSLR class image quality, etc. Yet, the market faces certain challenges, such as, technological complications.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1042011

Portugal Life Insurance Opportunities Key Trends, Size, Growth, Shares And Forecast Research Report 2020

Researchmoz added Most up-to-date research on "Life Insurance in Portugal, Key Trends and Opportunities to 2020" to its huge collection of research reports.
Timetrics 'Life Insurance in Portugal, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into the Portuguese life insurance segment, including:

An overview of the Portuguese life insurance segment

The Portuguese life insurance segments growth prospects by category

A comprehensive overview of the Portuguese economy and demographics

A comparison of the Portuguese life insurance segment with its regional counterparts

The various distribution channels in the Portuguese life insurance segment

Details of the competitive landscape in the life insurance segment in Portugal

Details of regulatory policy applicable to the Portuguese insurance industry

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1042014

Summary
Timetrics 'Life Insurance in Portugal, Key Trends and Opportunities to 2020' report provides a detailed outlook by product category for the Portuguese life insurance segment, and a comparison of the Portuguese insurance industry with its regional counterparts.

It provides key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, total assets, total investment income and retentions during the review period (20112015) and forecast period (20152020).

The report also analyzes distribution channels operating in the segment, gives a comprehensive overview of the Portuguese economy and demographics, and provides detailed information on the competitive landscape in the country.

The report brings together Timetrics research, modeling and analysis expertise, giving insurers access to information on segment dynamics and competitive advantages, and profiles of insurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure.

Scope
This report provides a comprehensive analysis of the life insurance segment in Portugal:

It provides historical values for the Portuguese life insurance segment for the reports 20112015 review period, and projected figures for the 20152020 forecast period.

It offers a detailed analysis of the key categories in the Portuguese life insurance segment, and market forecasts to 2020.

It provides a comparison of the Portuguese life insurance segment with its regional counterparts

It analyzes the various distribution channels for life insurance products in Portugal.

It profiles the top life insurance companies in Portugal and outlines the key regulations affecting them.

Reasons To Buy
Make strategic business decisions using in-depth historic and forecast market data related to the Portuguese life insurance segment, and each category within it.

Understand the demand-side dynamics, key market trends and growth opportunities in the Portuguese life insurance segment.

Assess the competitive dynamics in the life insurance segment.

Identify growth opportunities and market dynamics in key product categories.

Gain insights into key regulations governing the Portuguese insurance industry, and their impact on companies and the industry's future.

Key Highlights
Life insurance was the largest segment in the Portuguese insurance industry, accounting for 67.5% of gross written premium in 2015.

During the review period, the fall in life policies sales was caused by long-term low interest rates and a fall in the rate of household savings.

The unemployment rate is high in Portugal due to the adverse effect of the global economic and sovereign debt crises.

The countrys aging population is expected to increase demand for pension and annuity products over the forecast period, leading to a shift in the focus of life insurers.

The Portuguese life segment is highly concentrated, with the 10 leading insurers collectively accounting for 88.9% of the segments direct written premium in 2015.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1042014

US Anesthesiology Service Industry Key Trends, Size, Growth, Shares And Forecast Research Report (2017-2021)

Researchmoz added Most up-to-date research on "The US Anesthesiology Service Market: Size, Trends & Forecasts (2017-2021)" to its huge collection of research reports.

The report entitled “The US Anesthesiology Service Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the US anesthesia service market, with detailed analysis of market size and value, market share and economic impact of the industry. The analysis includes the market by value, by share of players, by segments, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US anesthesia service market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Envision Healthcare, Teamhealth and Mednax are some of the key players operating in the US anesthesiology service market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

    Envision Healthcare
    Mednax
    Teamhealth

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1042013

Executive Summary

Anesthesiology market is composed of two main elements which are anesthesia (drugs for medicinal purpose) and anesthesiologist (professional who are trained to use anesthesia). There are many equipments specifically designed for different surgical procedures like Anesthetic Vaporizer is used for vaporizing anesthetic; nasal oxygen set for delivering oxygen etc.

The US anesthesiology market is expected to increase at high growth rates during the forecasted period (2017-2021). The US anesthesiology market is supported by various growth drivers, such as growing geriatric population, increase in monitored anesthesia use, increasing chronic diseases and volume of surgeries etc. Yet, the market faces certain challenges, such as, side effects of anesthesia, high price of anesthesia equipment, etc. Few new market trends are also provided such as, increasing mid-level anesthesia provider, increasing anesthesiologist employment, technological enhancement of anesthesia devices, etc.

Table of Content

1. Executive Summary

2. Introduction2.1 Anesthesiology Market: An Overview
2.1.1 Elements of Anesthesiology
2.1.2 Types of Anesthesia
2.1.3 Anesthetic Equipment & Instruments
2.1.4 Anesthesia Side Effects
2.1.5 Segments in Anesthesiology Market

3. Market Analysis
3.1 The US Anesthesiology Service Market: An Analysis
3.1.1 The US Anesthesiology Service Market by Value
3.1.2 The US Anesthesiology Service Market by Segments
3.1.3 The US GIASC Market by Value
3.1.4 The US GIASC Market by Penetration In the US ASC Market
3.1.5 The US Anesthesiology Service Market by Number of Anesthesiologist

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increased Ambulatory Surgeries
4.1.2 Growing Geriatric Population
4.1.3 Increase in Monitored Anesthesia Use
4.1.4 New Drugs Approvals at Reduced Cost
4.1.5 Increasing Chronic Diseases and Volume of Surgeries
4.1.6 Increasing Utilization Of Deep Sedation For Endoscopic Procedures
4.2 Challenges
4.2.1 Side Effects of Anesthesia
4.2.2 Lack of Skilled Anesthesiologist
4.2.3 Regulatory Issues
4.2.4  High Price of Anesthesia Equipment
4.3 Market Trends
4.3.1 Increasing Mid-Level Anesthesia Provider
4.3.2 Increasing Anesthesiologist Employment
4.3.3 More Care Team and Certified Nurse Anesthetists
4.3.4 Technological Enhancement of Anesthesia Devices
4.3.5 Growing ASC Market

5. Competitive Landscape
5.1 The US Anesthesiology Service Market Players by Share
5.2 The U.S. Anesthesia Market Player by Mergers and Acquisitions
5.3 The US ASC Market Share by Players
5.4 The US Anesthesia Service Market by Other Private Providers
5.5 The US Anesthesiology Service Market Merger and Acquisitions

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1042013

Global Point of Sale (POS) Terminal Market Key Trends, Size, Growth, Shares And Forecast Research Report (2017-2021)

Researchmoz added Most up-to-date research on "Global Point of Sale (POS) Terminal Market: Size, Trends & Forecasts (2017-2021)" to its huge collection of research reports.

The report entitled “Global Point of Sale (POS) Terminal Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global POS market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, volume and by segmentation.

The report also includes a detailed regional analysis of the POS market in regions such as Asia Pacific, Europe, Latin America, Middle East and Africa and US/ Canada. Under competitive landscape, different players in the POS market have been compared on the basis of revenue and market capitalization.

Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global POS market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1042012

Ingenico Group, Verifone Systems Inc., Toshiba Tec Corporation and PAX Global Technology Limited are some of the key players operating in the global POS market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Country Coverage

- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
- US/ Canada

Company Coverage

- Ingenico Group
- Verifone Systems Inc.
- Toshiba Tec Corporation
- PAX Global Technology Limited

Executive Summary

The Global POS market can be segmented on the basis of component, applicability and product. On the basis of component, the market can further be divided into hardware and software. On the basis of applicability, the market can be divided into hospitality, grocery, healthcare, field service, restaurants & retail small and medium business. On the basis of product, the market can be divided into fixed and wireless POS terminal.

The global POS market is expected to increase at a healthy rate during the forecast period (2017-2021). The global POS market is supported by various growth drivers, such as rising e- commerce sales, increasing shipments of NFC enabled handsets, upsurge in number of hotels, resorts and spas, boom in number of smartphone users and increased use of mobile POS by small and medium enterprises. However, non compliance to PCI and data security risk are some of the challenges faced by the market. Growing use of cloud based POS, android POS hardware and increasing use of mobile wallets by consumers are some of the latest trends in the global POS market.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1042012

At A CAGR Of 10.31% Global Automated Trading Industry Will Grow Steadily During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Automated Trading Market 2016-2020" to its huge collection of research reports.

The automated trading systems are also referred to as algorithmic trading or mechanical trading systems where it allows the trader to establish specific rules for both trade entries and trade exits. They are generally programmed in a way so that they can be automatically executed through computer systems. The entry and exit in the trade is based on the moving average crossovers. Sometimes it also requires the understanding of the programming language that is specific to the users trading platform. The automated trading requires the use of software that is linked to a direct access broker and the specific rules that are written in the proprietary language in the platform. For instance, the TradeStation platform uses the Easy programming language.

Technavios analysts forecast the global automated trading market to grow at a CAGR of 10.31% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global automated trading market for 2016-2020. To calculate the market size, the report considers the net commission earned from automated trading platform providers in the Americas, APAC, and EMEA.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=840978

Technavio's report, Global Automated Trading Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Citadel
KCG
Optiver
Two Sigma Investments

Other prominent vendors
DRW Trading
Flow Traders
Hudson River Trading
Jump Trading
RSJ Algorithmic Trading
Spot Trading
Sun Trading
Tower Research Capital
Tradebot Systems
Virtu Financial

Market driver
Increased integration of financial markets
For a full, detailed list, view our report

Market challenge
Lack of awareness in automated trading
For a full, detailed list, view our report

Market trend
Advancements in technology
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=840978

At A CAGR Of 4.05% Global Industrial Fasteners Industry Will Grow Steadily During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Industrial Fasteners Market 2016-2020" to its huge collection of research reports.

Industrial fasteners are efficient tools used to connect two or more parts of a product, enabling the development of a superior quality and reliable end-product. Various types of industrial fasteners such as externally threaded, standard, and aerospace grade are used across sectors such as automotive, construction, mining, marine, nuclear, petrochemicals, railways, and aerospace. Several application-specific fasteners engineered with higher strength and durability to meet the specific needs of end-users are available in the market.

Technavios analysts forecast the global industrial fasteners market to grow at a CAGR of 4.05% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global industrial fasteners market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fasteners in various end-user segments and the average price of various types of industrial fasteners, vis--vis nuts, bolts, and screws among others, have been considered in determining the market size.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=840983

Technavio's report, Global Industrial Fasteners Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Acument Global Technologies
Alcoa
Bulten
ITW

Other prominent vendors
American Industrial Partners, Atlas Bolt and Screw, Air Industries, Ajax Metal Processing, Allfast Fastening Systems, Aoyama Seisakusho, ARaymond, ARNOLD Umformtechnik, ASYST Technologies, Automatic Screw Machine Products, Avibank Manufacturing, AVK Industrial Products, AAA Aircraft Supply, baier & michels, Cardinal Fastener, Cherry Aerospace, Cold Heading Company, Delo Screw Products, Wrth Des Moines Bolt, Dokka Fasteners, Doncasters, EBC Industries, EJOT Holding, Pentair Engineered Electrical & Fastening Solutions, Fabristeel, FACIL Flexible Fastening Solutions, Fastenal, Fatigue Technology, Federal Screw Works, Ferry Cap & Set Screw, Fontana Luigi SpA, General Fasteners, GESIPA Fasteners USA, Global Fastener Alliance, SPS Greer Stop Nut, Hilti, Infasco, Indiana Automotive Fasteners, KAMAX Holding, Nedschroef Ultra Fasteners, Lamons, LISI, MacLean-Fogg, Marmon, MNP, Monogram Aerospace Fasteners, Nitto Seiko, Nucor, Nelson Stud Welding, Net Shaped Solutions, Nifco, Nylok, Pan American Screw, Park-Ohio Holdings, PB Fasteners, PennEngineering, PIOLAX, Powers Fasteners, RB&W Manufacturing, Robertson, Sundram Fasteners, Saturn Fasteners, SFS, Shanghai Prime Machinery, Shur-Lok, Southco, Specialty Bar Products Company, Stanley Black & Decker, Supply Technologies, TriMas Corporation, and Western Builders Supply.

Market driver
Increased demand from end-users such as nuclear and construction industries
For a full, detailed list, view our report

Market challenge
Structural adhesives are alternatives to mechanical fasteners
For a full, detailed list, view our report

Market trend
Eliminating defective fasteners with 3D inspection
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=840983

At A CAGR Of 10.16% Global Fantasy Sport Market Grow During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Fantasy Sports Market 2016-2020" to its huge collection of research reports.

Fantasy sports is a type of online game where participants assemble virtual teams of professional players of a particular sport. Such teams then compete based on their actual statistical performances in the actual games being played by them. Based on this performance of the chosen players of the fantasy team, the points for the team are compiled and totaled. The point system for fantasy leagues are calculated by a league commissioner, or may also be calculated by tracking actual results of the professional sport.

Technavios analysts forecast the global fantasy sport to grow at a CAGR of 10.16% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global thoracic surgery market for 2016-2020. To calculate the market size, the report considers the revenue generated from the league fee paid by end-users to participate in fantasy sports events.
The market is divided into the following segments based on geography:
North America
Europe
APAC
ROW

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=840984

Technavio's report, Global Fantasy Sports Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
CBS
DraftKings
ESPN
FanDuel
Yahoo

Other prominent vendors
Ballr
Bovada
FantasyAces
Fantrax

Market driver
Direct control over operations and increased social media optimizations
For a full, detailed list, view our report

Market challenge
Increasing traction of mobile video games and traditional e-sports
For a full, detailed list, view our report

Market trend
Partnerships between pro leagues and daily fantasy vendors
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=840984

Department Stores in Germany 2016-2020 | Now Available at Researchmoz.us

Researchmoz added Most up-to-date research on "Department Stores in Germany 2016-2020" to its huge collection of research reports.

The retail industry can be divided into two broad segments on the basis of the channel of operation: brick-and-mortar retail format (or, store-based retail formats/offline retail format), and online retail format. Online retail is a part of B2C e-commerce and typically refers to commercial activities over the Internet. The retail industry is also classified into traditional retail and organized retail, on the basis of the business structure and retail space formation. Major retail formats of the organized retail sector are specialized stores, department stores, supermarkets, and hypermarkets

Technavios analysts forecast the department stores in Germany to grow at a CAGR of 0.69% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the department stores in Germany for 2016-2020. To calculate the market size, the report considers the revenue generated from the retail sales of products to individual customers by the department stores in Germany.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=840985

Technavio's report, Department Stores in Germany 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Breuninger
C&A
GALERIA Kaufhof
Karstadt Warenhaus
Woolworth
Other prominent vendors
Galeries Lafayette
Peek & Cloppenburg
Hema
Ludwig Beck
Mller
Apropos
Marimekko
Zara
Mitsukoshi
Manufactum
Strauss Innovation

Market driver
Favorable micro-location and concept of having everything under one roof
For a full, detailed list, view our report

Market challenge
Changing buying behavior due to increasing internet retailing and e-commerce
For a full, detailed list, view our report

Market trend
Omni-channel capabilities to support department stores
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=840985

At A CAGR Of 10.16% Latin America Cloud Computing Market Will Grow During The Period 2016-2020

Researchmoz added Most up-to-date research on "Cloud Computing Market in Latin America 2016-2020" to its huge collection of research reports.

Cloud computing solutions are IT solutions deployed over the ICT systems. These solutions eliminate the need to install in-house hardware and software. The cost of in-house IT solutions is relatively low as compared with cloud-based solutions among most of the IT deployment models. Cloud computing solutions have been implemented in a majority of organizations, irrespective of the size of businesses. Firms with high IT budgets are willing to spend more on flexible IT solutions and cloud computing solutions. However, a few firms still use on-premise solutions due to cloud security concerns and the resistance from the in-house IT department.

Technavios analysts forecast the cloud computing market in Latin Americato grow at a CAGR of 10.16% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the cloud computing market in Latin America for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of enterprise cloud computing solutions and services by vendors in Latin America.

Technavio's report, Cloud Computing Market in Latin America 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=850935

Key vendors
Amazon Web Services (AWS)
Microsoft
IBM
Google
Salesforce

Other prominent vendors
HPE
Oracle
Rackspace
Red Hat
SAP
Telefonica
TIVIT Technology

Market driver
Adoption of advanced technologies to support Industry 4.0
For a full, detailed list, view our report

Market challenge
Technical complexities in cloud implementation
For a full, detailed list, view our report

Market trend
Emergence of cloud platform for machine-to-machine and Internet of Things
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=850935

Global Sample Preparation Market Is Expected To Reach A Valuation Of US$8.3 bn Exhibiting A CAGR Of 6.6% From 2016 To 2024

Researchmoz added Most up-to-date research on "Sample Preparation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" to its huge collection of research reports.

This report on the global sample preparation market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as increasing preference for technologically advanced services, product innovation, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global sample preparation market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=789829

Based on product type, the global sample preparation market has been segmented into sample preparation instruments, consumables, sample preparation kits, and accessories. The market has been further studied from the point of view of major applications of sample preparation. These are proteomics, genomics, epigenomics, transcriptomics, and metabolomics. Pharmaceutical industries, biotechnology, diagnostic laboratories, academic institutes, and others form the major end-users of the sample preparation market. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Geographically, the global sample preparation market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These are the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, and South Africa. The report also profiles major players in the sample preparation market based on various attributes such as company overview, financial overview, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agilent Technologies, Bio-Rad Laboratories, Biotage AB, Danaher Corporation, F Hoffman La Roche, Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., and Waters Corporation.

The global sample preparation market has been segmented as follows:

Global Sample Preparation Market, by Technique
- Solid Phase Extraction
- Liquid-liquid Extraction
- Protein Precipitation
- Others (QuEChERS, SFE, etc.)

Global Sample Preparation Market, by Product

- Sample Preparation Instruments
- Consumables
- Sample Preparation Kits
- Accessories

Global Sample Preparation Market, by End-user

- Pharmaceutical Industries
- Biotechnology
- Diagnostic Laboratories
- Academic Institutes
- Others (food industry, forensics, and environmental testing)

Global Sample Preparation Market, by Application

- Genomics
- Proteomics
- Epigenomics
- Transcriptomics
- Metabolomics

Global Sample Preparation Market, by Geography

- North America
- U.S.
- Canada
- Asia Pacific
- China
- Japan
- Rest of APAC
- Europe
- U.K.
- Germany
- Rest of Europe
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=789829

Global Revenue Generated By The Hybrid Power Systems Market Is Anticipated To Rise US$703.5 Mn By 2024 At A 6.1% CAGR Therein

Researchmoz added Most up-to-date research on "Hybrid Power Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" to its huge collection of research reports.

The research study is designed to analyze the global hybrid power systems market. The market is calculated in terms of revenue (US$ Mn) based on the annual sales of hybrid power systems. The market for hybrid power systems has been segmented on the basis of type, end-use, and country/region. The global hybrid power systems market, based on type, has been segmented into wind-solar-diesel-hybrid, PV-diesel-hybrid, and others. On the basis of end-use, the hybrid power systems market has been segmented into residential, rural facility electrification, and others.

The regional segments included in this study are North America, Europe, Asia Pacific, Middle East and Africa (MEA), and South and Central America (SCA). These regional segments are further divided into country-wise segments. The report provides a detailed growth forecast for the 2016–2024 period, considering 2015 as the baseline year. Projections have been provided for revenue (US$ Mn) through the annual sales of hybrid power systems.

The report includes the key market dynamics affecting the demand for hybrid power systems. As a part of our market dynamics analysis, we have analyzed the market drivers, market restraints, and market opportunities. A comprehensive competitive landscape, which includes company market share analysis and market attractiveness analysis, has also been provided in this report. The report also provides a detailed industry analysis of the global hybrid power systems market with the help of Porter’s Five Forces model. The Porter’s Five Forces analysis aids in understanding the five major forces that affect the industry structure and profitability of the global hybrid power systems market. The forces analyzed are the bargaining power of buyers, bargaining power of suppliers, threat of new entrants, threat of substitutes, and degree of competition.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=789839

The study also includes the value chain of the global hybrid power systems market which provides a glimpse of key suppliers, manufacturers, and distribution channel as well as interaction of suppliers and buyers with end-users. The company market share analysis has been done considering the revenue and global penetration of key market players in the hybrid power systems industry. The market attractiveness involves benchmarking and ranking each technology and region on the basis of numerous parameters. The parameters selected are likely to have a pronounced effect on the demand for each technology in the current scenario as well as in the near future.

Key participants in the global hybrid power systems market include Bergey WindPower Co., BORG Inc., Guangzhou HY Energy Technology Limited Corp., Kestrel Renewable Energy, KYOCERA Corporation, Panasonic Corporation, Schneider Electric SE, Sharp Electronics, Siemens AG, and Suzlon Group. This report provides an overview of these companies, followed by their financial revenues, business strategies, technical information, and recent developments.

Global Hybrid Power Systems Market: Type Analysis

- Wind-Solar-Diesel-Hybrid
- PV-Diesel-Hybrid
- Others

Global Hybrid Power Systems Market: End-Use Analysis

- Residential
- Rural Facility Electrification
- Others

Global Hybrid Power Systems Market: Regional Segment Analysis

- North America
- U.S.
- Canada
- Mexico
- Europe
- Turkey
- Kazakhstan
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- Australia
- Indonesia
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Tanzania
- Egypt
- UAE
- Rest of MEA
- South and Central America (SCA)
- Brazil
- Chile
- Rest of SCA

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=789839